Li Tingting, Yan Zhipeng, Fan Yajie, Fan Xinbiao, Li Aolin, Qi Zhongwen, Zhang Junping
First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, National Clinical Research Center for Chinese Medicine Acupuncture and Moxibustion, Tianjin, China.
Graduate School, Tianjin University of Traditional Chinese Medicine, Tianjin, China.
Front Cardiovasc Med. 2023 Jan 9;9:1077290. doi: 10.3389/fcvm.2022.1077290. eCollection 2022.
Myocardial infarction is the leading cause of death and disability worldwide, and the development of new treatments can help reduce the size of myocardial infarction and prevent adverse cardiovascular events. Cardiac repair after myocardial infarction can effectively remove necrotic tissue, induce neovascularization, and ultimately replace granulation tissue. Cardiac inflammation is the primary determinant of whether beneficial cardiac repair occurs after myocardial infarction. Immune cells mediate inflammatory responses and play a dual role in injury and protection during cardiac repair. After myocardial infarction, genetic ablation or blocking of anti-inflammatory pathways is often harmful. However, enhancing endogenous anti-inflammatory pathways or blocking endogenous pro-inflammatory pathways may improve cardiac repair after myocardial infarction. A deficiency of neutrophils or monocytes does not improve overall cardiac function after myocardial infarction but worsens it and aggravates cardiac fibrosis. Several factors are critical in regulating inflammatory genes and immune cells' phenotypes, including DNA methylation, histone modifications, and non-coding RNAs. Therefore, strict control and timely suppression of the inflammatory response, finding a balance between inflammatory cells, preventing excessive tissue degradation, and avoiding infarct expansion can effectively reduce the occurrence of adverse cardiovascular events after myocardial infarction. This article reviews the involvement of neutrophils, monocytes, macrophages, and regulatory T cells in cardiac repair after myocardial infarction. After myocardial infarction, neutrophils are the first to be recruited to the damaged site to engulf necrotic cell debris and secrete chemokines that enhance monocyte recruitment. Monocytes then infiltrate the infarct site and differentiate into macrophages and they release proteases and cytokines that are harmful to surviving myocardial cells in the pre-infarct period. As time progresses, apoptotic neutrophils are cleared, the recruitment of anti-inflammatory monocyte subsets, the polarization of macrophages toward the repair phenotype, and infiltration of regulatory T cells, which secrete anti-inflammatory factors that stimulate angiogenesis and granulation tissue formation for cardiac repair. We also explored how epigenetic modifications regulate the phenotype of inflammatory genes and immune cells to promote cardiac repair after myocardial infarction. This paper also elucidates the roles of alarmin S100A8/A9, secreted frizzled-related protein 1, and podoplanin in the inflammatory response and cardiac repair after myocardial infarction.
心肌梗死是全球范围内导致死亡和残疾的主要原因,开发新的治疗方法有助于缩小心肌梗死面积并预防不良心血管事件。心肌梗死后的心脏修复可有效清除坏死组织,诱导血管新生,并最终替代肉芽组织。心脏炎症是心肌梗死后是否发生有益心脏修复的主要决定因素。免疫细胞介导炎症反应,并在心脏修复过程中的损伤和保护中发挥双重作用。心肌梗死后,对抗炎途径进行基因消融或阻断往往是有害的。然而,增强内源性抗炎途径或阻断内源性促炎途径可能会改善心肌梗死后的心脏修复。中性粒细胞或单核细胞缺乏并不会改善心肌梗死后的整体心脏功能,反而会使其恶化并加重心脏纤维化。有几个因素在调节炎症基因和免疫细胞表型方面至关重要,包括DNA甲基化、组蛋白修饰和非编码RNA。因此,严格控制并及时抑制炎症反应,在炎症细胞之间找到平衡,防止过度的组织降解,并避免梗死灶扩大,可有效减少心肌梗死后不良心血管事件的发生。本文综述了中性粒细胞、单核细胞、巨噬细胞和调节性T细胞在心肌梗死后心脏修复中的作用。心肌梗死后,中性粒细胞最先被招募到受损部位,吞噬坏死细胞碎片并分泌趋化因子,增强单核细胞的招募。然后单核细胞浸润梗死部位并分化为巨噬细胞,它们在梗死前期释放对存活心肌细胞有害的蛋白酶和细胞因子。随着时间的推移,凋亡的中性粒细胞被清除,抗炎单核细胞亚群被招募,巨噬细胞向修复表型极化,调节性T细胞浸润,后者分泌抗炎因子,刺激血管生成和肉芽组织形成以进行心脏修复。我们还探讨了表观遗传修饰如何调节炎症基因和免疫细胞的表型,以促进心肌梗死后的心脏修复。本文还阐明了警报素S100A8/A9、分泌型卷曲相关蛋白1和血小板内皮细胞黏附分子在心肌梗死后炎症反应和心脏修复中的作用。